Kavita Batra (Medicine) published a study, "Serum-soluble ST2 as a novel biomarker for COVID-19 severity and mortality: A systematic review and meta-analysis," in the Journal of Health and Social Sciences. This meta-analysis identifies serum-soluble ST2 as a significant biomarker for assessing the severity and predicting mortality in COVID-19 patients, demonstrating its potential for guiding clinical decisions and treatment strategies. Equipped with the clinical training in dental surgery and doctorate in public health, Batra actively contributes and offers a combined expertise or collective knowledge to several multidisciplinary research projects at local, national, and international level.